Alteogen to Hold Shareholder IR in Daejeon on the 15th to Explain Small-Scale Merger with Alteogen Biologics
Alteogen announced in a regulatory filing on the 8th that it will hold an investor relations (IR) session on the 15th to help shareholders better understand its decision to merge with its subsidiary, Alteogen Biologics. ■ Event Overview The briefing will take place from 2 p.m. to 4 p.m. on the 15th

Alteogen announced in a regulatory filing on the 8th that it will hold an investor relations (IR) session on the 15th to help shareholders better understand its decision to merge with its subsidiary, Alteogen Biologics.
■ Event Overview The briefing will take place from 2 p.m. to 4 p.m. on the 15th at the Lee Soo-min Memorial Hall, Hannam University Daedeok Valley Campus, located at 1646 Yuseong-daero, Yuseong-gu, Daejeon. It is open to Alteogen shareholders and will be conducted as an in-person meeting. The main agenda item is the small-scale merger between Alteogen and its subsidiary, with presentations and a question-and-answer (Q&A) session scheduled.
■ How to Attend Shareholders wishing to attend must verify their shareholder status on-site by presenting a balance certificate or their mobile trading system (MTS) screen. The company stated that those who fail to verify their shareholder status may be restricted from attending the event that day.
■ Disclosure of Materials The briefing is hosted by Alteogen itself, and the event was confirmed on October 6. Related IR materials will be posted on the Korea Exchange's electronic disclosure system (KIND) website on the 15th, the day of the event.
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.



